| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
269,764,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
11,686,762 |
Avg
Vol: |
5,279,592 |
| 52
Week Range: |
$76.25 - $76.25 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ BIOTECHNOLOGY |
| |
NASDAQ COMPOSITE |
|
NASDAQ-100 |
| |
S&P 500 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-21 |
2023-12-19 |
2023-06-20 |
2022-06-20 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Syron Richard F |
Director |
– • – |
2009-05-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
2,511 |
|
- |
|
| Cooney Charles L |
Director |
– • – |
2009-05-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
10,664 |
|
- |
|
| Carpenter Robert J |
Director |
– • – |
2009-05-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
30,525 |
|
- |
|
| Berthiaume Douglas A |
Director |
– • – |
2009-05-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
68,658 |
|
- |
|
| Mcgillicudy Cornelius III |
Director |
– • – |
2009-05-21 |
4/A |
OE |
$0.00 |
$0 |
D/D |
2,500 |
2,500 |
|
- |
|
| Syron Richard F |
Director |
– • – |
2009-05-21 |
4/A |
OE |
$0.00 |
$0 |
D/D |
2,500 |
2,511 |
|
- |
|
| Carpenter Robert J |
Director |
– • – |
2009-05-21 |
4/A |
OE |
$0.00 |
$0 |
D/D |
2,500 |
30,525 |
|
- |
|
| Dzau Victor J |
Director |
– • – |
2009-05-21 |
4/A |
OE |
$0.00 |
$0 |
D/D |
2,500 |
2,500 |
|
- |
|
| Cooney Charles L |
Director |
– • – |
2009-05-21 |
4/A |
OE |
$0.00 |
$0 |
D/D |
2,500 |
10,664 |
|
- |
|
| Boudreaux Gail |
Director |
– • – |
2009-05-21 |
4/A |
OE |
$0.00 |
$0 |
D/D |
2,500 |
2,500 |
|
- |
|
| Berthiaume Douglas A |
Director |
– • – |
2009-05-21 |
4/A |
OE |
$0.00 |
$0 |
D/D |
2,500 |
68,658 |
|
- |
|
| Carpenter Robert J |
Director |
– • – |
2009-05-15 |
4 |
AS |
$59.40 |
$86,244 |
D/D |
(1,452) |
28,025 |
|
- |
|
| Carpenter Robert J |
Director |
– • – |
2009-05-15 |
4 |
OE |
$20.59 |
$29,897 |
D/D |
1,452 |
29,477 |
|
- |
|
| Carpenter Robert J |
Director |
– • – |
2009-05-14 |
4 |
AS |
$60.33 |
$603,277 |
D/D |
(10,000) |
28,025 |
|
- |
|
| Carpenter Robert J |
Director |
– • – |
2009-05-14 |
4 |
OE |
$20.59 |
$205,900 |
D/D |
10,000 |
38,025 |
|
- |
|
| Carpenter Robert J |
Director |
– • – |
2009-05-13 |
4 |
AS |
$60.62 |
$606,238 |
D/D |
(10,000) |
28,025 |
|
- |
|
| Carpenter Robert J |
Director |
– • – |
2009-05-13 |
4 |
OE |
$20.59 |
$205,900 |
D/D |
10,000 |
38,025 |
|
- |
|
| Cooney Charles L |
Director |
– • – |
2009-05-13 |
4 |
S |
$60.19 |
$180,570 |
D/D |
(3,000) |
8,164 |
|
- |
|
| Carpenter Robert J |
Director |
– • – |
2009-05-12 |
4 |
AS |
$60.70 |
$606,957 |
D/D |
(10,000) |
28,025 |
|
- |
|
| Carpenter Robert J |
Director |
– • – |
2009-05-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
38,025 |
|
- |
|
| Carpenter Robert J |
Director |
– • – |
2009-05-11 |
4 |
AS |
$61.28 |
$612,775 |
D/D |
(10,000) |
28,025 |
|
- |
|
| Carpenter Robert J |
Director |
– • – |
2009-05-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
38,025 |
|
- |
|
| Cooney Charles L |
Director |
– • – |
2009-04-24 |
4 |
S |
$53.35 |
$213,386 |
D/D |
(4,000) |
11,164 |
|
- |
|
| Desrosier Thomas |
Sr VP, General Counsel |
• – – |
2009-04-23 |
4 |
A |
$52.10 |
$196,514 |
I/I |
3,772 |
3,772 |
|
- |
|
| Meeker David P |
ExecVP,Therapeutics,Biosurgery |
• – – |
2009-04-23 |
4 |
B |
$51.95 |
$103,906 |
D/D |
2,000 |
4,227 |
2.74 |
- |
|
604 Records found
|
|
Page 8 of 25 |
|
|
